Catenin beta-1 mRNA 3'-untranslated region (CTNNB1 mRNA 3'-UTR) (CTNNB1 mRNA 3'-UTR)

The Catenin beta-1 (CTNNB1) mRNA 3'-untranslated region (3'-UTR) is a critical regulatory segment of the messenger RNA that encodes the beta-catenin protein (UniProt P35222). This region contains numerous binding sites for microRNAs (miRNAs) and RNA-binding proteins that dictate the stability and translational efficiency of the transcript (He et al., Nature 2007). In many cancers, the Wnt/beta-catenin signaling pathway is constitutively active, often due to the loss of negative regulation at the mRNA level (Kim et al., Cell Death & Disease 2011). Therapeutic strategies targeting the CTNNB1 3'-UTR aim to reduce beta-catenin protein expression by utilizing miRNA mimics, such as miR-34a, or antisense oligonucleotides that promote mRNA degradation or block translation. While targeting this region offers a way to modulate a traditionally "undruggable" transcription factor, challenges include ensuring tissue-specific delivery and avoiding systemic immune responses. Clinical candidates like MRX34 have explored this mechanism, highlighting both the potential and the safety hurdles of RNA-targeted therapies in oncology (Beg et al., Investigational New Drugs 2017). The 3'-UTR is also a site for genetic polymorphisms that can alter miRNA binding affinity, potentially serving as a biomarker for disease susceptibility or treatment response. Overall, the CTNNB1 mRNA 3'-UTR represents a sophisticated regulatory hub that is increasingly being leveraged for precision medicine in Wnt-driven malignancies.

Other names

Beta-catenin mRNA 3'-UTRCTNNB1 3'-UTRCTNNB1 3'-untranslated regionCatenin beta-1 3'-UTR

RNA interference (RNAi), miRNA-mediated translational repression, and mRNA degradation via the RNA-induced silencing complex (RISC) (He et al., Nature 2007).